The psmα locus regulates production of Staphylococcus aureus alpha-toxin during infection

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3350-3358

  Berube, Bryan J ^a   Sampedro, Georgia R ^a   Otto, Michael ^b   Wardenburg, Juliane Bubeck ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PHENOL SOLUBLE MODULIN ALPHA; SMALL INTERFERING RNA; STAPHYLOCOCCUS ALPHA TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE LOCUS; GENE OVEREXPRESSION; HLA SYSTEM; HOST PATHOGEN INTERACTION; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; OPTICAL DENSITY; PHENOTYPE; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, BACTERIAL; GENE KNOCKOUT TECHNIQUES; HEMOLYSIN PROTEINS; MICE; MICE, INBRED C57BL; PLASMIDS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84904759616     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00089-14     Document Type: Article

References (70)

1. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M. 2007. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin. Infect. Dis. 45:1132-1140. http://dx.doi.org/10.1086/522186.
2. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
3. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States.JAMA298:1763-1771. http://dx.doi.org/10.1001/jama.298.15.1763.
4. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687. http://dx.doi.org /10.1128/CMR.00081-09.
5. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568. http://dx.doi.org/10.1016/S0140-6736(09)61999-1.
6. Lee BY, Singh A, David MZ, Bartsch SM, Slayton RB, Huang SS, Zimmer SM, Potter MA, Macal CM, Lauderdale DS, Miller LG, Daum RS. 2013. The economic burden of community-associated methicillinresistant Staphylococcus aureus (CA-MRSA). Clin. Microbiol. Infect. 19: 528-536. http://dx.doi.org/10.1111/j.1469-0691.2012.03914.x.
7. CDC. 2013. Antibiotic resistance threats in the United States. CDC, Atlanta, GA. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar -threats-2013-508.pdf.
8. Proctor RA. 2012. Is there a future for a Staphylococcus aureus vaccine? Vaccine 30:2921-2927. http://dx.doi.org/10.1016/j.vaccine.2011.11.006.
9. Bagnoli F, Bertholet S, Grandi G. 2012. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front. Cell. Infect. Microbiol. 2:16. http://dx.doi.org/10.3389/fcimb.2012.00016.
10. Cheung GY, Otto M. 2012. The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin. Ther. Targets 16:601-612. http://dx.doi.org/10.1517/14728222.2012 .682573.
11. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. 2011. Role of the accessory gene regulator agr in community-associated methicillinresistant Staphylococcus aureus pathogenesis. Infect. Immun. 79:1927-1935. http://dx.doi.org/10.1128/IAI.00046-11.
12. Gray B, Hall P, Gresham H. 2013. Targeting agr- and agr-like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections. Sensors 13:5130-5166. http://dx .doi.org/10.3390/s130405130.
13. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13:1405-1406. http://dx .doi.org/10.1038/nm1207-1405.
14. Bubeck Wardenburg J, Schneewind O. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205:287-294. http://dx .doi.org/10.1084/jem.20072208.
15. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, DeLeo FR. 2010. Targeting of alphahemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202:1050-1058. http://dx.doi.org/10.1086/656043.
16. Powers ME, Kim HK, Wang Y, Bubeck Wardenburg J. 2012. ADAM10 mediates vascular injury induced by Staphylococcus aureus alphahemolysin. J. Infect. Dis. 206:352-356. http://dx.doi.org/10.1093/infdis /jis192.
17. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. 1994. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect. Immun. 62:2478-2482.
18. Jonsson P, Lindberg M, Haraldsson I, Wadstrom T. 1985. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect. Immun. 49:765-769.
19. Berube BJ, Bubeck Wardenburg J. 2013. Staphylococcus aureus alphatoxin: nearly a century of intrigue. Toxins (Basel) 5:1140-1166. http://dx .doi.org/10.3390/toxins5061140.
20. Kielian T, Cheung A, Hickey WF. 2001. Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect. Immun. 69:6902-6911. http://dx.doi.org/10.1128/IAI.69 .11.6902-6911.2001.
21. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, Bubeck Wardenburg J, Schneewind O, Otto M, DeLeo FR. 2011. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204:937-941. http: //dx.doi.org/10.1093/infdis/jir441.
22. Wilke GA, Bubeck Wardenburg J. 2010. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc. Natl. Acad. Sci. U. S. A. 107:13473-13478. http://dx.doi .org/10.1073/pnas.1001815107.
23. Inoshima I, Inoshima N, Wilke GA, Powers ME, Frank KM, Wang Y, Bubeck Wardenburg J. 2011. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17:1310-1314. http://dx.doi.org/10.1038/nm.2451.
24. Inoshima N, Wang Y, Wardenburg JB. 2012. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 132:1513-1516. http://dx.doi.org/10.1038/jid.2011.462.
25. Peschel A, Otto M. 2013. Phenol-soluble modulins and staphylococcal infection. Nat. Rev. Microbiol. 11:667-673. http://dx.doi.org/10.1038 /nrmicro3110.
26. Chatterjee SS, Joo HS, Duong AC, Dieringer TD, Tan VY, Song Y, Fischer ER, Cheung GY, Li M, Otto M. 2013. Essential Staphylococcus aureus toxin export system. Nat. Med. 19:364-367. http://dx.doi.org/10 .1038/nm.3047.
27. Kretschmer D, Gleske AK, Rautenberg M, Wang R, Koberle M, Bohn E, Schoneberg T, Rabiet MJ, Boulay F, Klebanoff SJ, van Kessel KA, van Strijp JA, Otto M, Peschel A. 2010. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7:463-473. http://dx.doi.org/10.1016/j.chom.2010.05.012.
28. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13:1510-1514. http://dx.doi.org/10.1038/nm1656.
29. Surewaard BG, de Haas CJ, Vervoort F, Rigby KM, DeLeo FR, Otto M, van Strijp JA, Nijland R. 2013. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell. Microbiol. 15:1427-1437. http://dx.doi.org/10.1111/cmi.12130.
30. Rautenberg M, Joo HS, Otto M, Peschel A. 2011. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J. 25:1254-1263. http://dx.doi.org/10.1096/fj.10-175208.
31. Otto M. 2010. Basis of virulence in community-associated methicillinresistant Staphylococcus aureus. Annu. Rev. Microbiol. 64:143-162. http: //dx.doi.org/10.1146/annurev.micro.112408.134309.
32. Li M, Cheung GY, Hu J, Wang D, Joo HS, DeLeo FR, Otto M. 2010. Comparative analysis of virulence and toxin expression of global community- associated methicillin-resistant Staphylococcus aureus strains. J. Infect. Dis. 202:1866-1876. http://dx.doi.org/10.1086/657419.
33. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M, Otto M. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32:150-158. http://dx.doi.org/10.1016/j.molcel.2008.08.005.
34. Kaito C, Saito Y, Ikuo M, Omae Y, Mao H, Nagano G, Fujiyuki T, Numata S, Han X, Obata K, Hasegawa S, Yamaguchi H, Inokuchi K, Ito T, Hiramatsu K, Sekimizu K. 2013. Mobile genetic element SCCmecencoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS Pathog. 9:e1003269. http://dx.doi.org/10.1371 /journal.ppat.1003269.
35. Ragle BE, Bubeck Wardenburg J. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77:2712-2718. http://dx.doi.org/10.1128 /IAI.00115-09.
36. Menzies BE, Kernodle DS. 1994. Site-directed mutagenesis of the alphatoxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model. Infect. Immun. 62:1843-1847.
37. DeLeo FR, Kennedy AD, Chen L, Bubeck Wardenburg J, Kobayashi SD, Mathema B, Braughton KR, Whitney AR, Villaruz AE, Martens CA, Porcella SF, McGavin MJ, Otto M, Musser JM, Kreiswirth BN. 2011. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 108: 18091-18096. http://dx.doi.org/10.1073/pnas.1111084108.
38. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS. 2008. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 198:561-570. http: //dx.doi.org/10.1086/590157.
39. Ragle BE, Karginov VA, Bubeck Wardenburg J. 2010. Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob. Agents Chemother. 54:298-304. http://dx.doi.org /10.1128/AAC.00973-09.
40. Tkaczyk C, Hua L, Varkey R, Shi Y, Dettinger L, Woods R, Barnes A, MacGill RS, Wilson S, Chowdhury P, Stover CK, Sellman BR. 2012. Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin. Vaccine Immunol. 19:377-385. http: //dx.doi.org/10.1128/CVI.05589-11.
41. Grosz M, Kolter J, Paprotka K, Winkler AC, Schafer D, Chatterjee SS, Geiger T, Wolz C, Ohlsen K, Otto M, Rudel T, Sinha B, Fraunholz M. 2014. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell. Microbiol. 16:451-465. http://dx.doi.org/10.1111/cmi.12233.
42. Tkaczyk C, Hamilton MM, Datta V, Yang XP, Hilliard JJ, Stephens GL, Sadowska A, Hua L, O'Day T, Suzich J, Stover CK, Sellman BR. 2013. Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model. PLoS One 8:e75103. http://dx.doi.org/10.1371/journal.pone.0075103.
43. Bubeck Wardenburg J, Patel RJ, Schneewind O. 2007. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75:1040-1044. http://dx.doi.org/10.1128/IAI .01313-06.
44. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS. 2006. Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J. Infect. Dis. 194:1267-1275. http://dx.doi.org/10.1086/508210.
45. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol. Gen. Genet. 202:58-61. http://dx.doi.org/10 .1007/BF00330517.
46. Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P. 1988. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J. Bacteriol. 170:4365-4372.
47. Reyes D, Andrey DO, Monod A, Kelley WL, Zhang G, Cheung AL. 2011. Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus. J. Bacteriol. 193:6020-6031. http: //dx.doi.org/10.1128/JB.05436-11.
48. Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, Moghazeh S. 1995. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248:446-458.
49. Lina G, Jarraud S, Ji G, Greenland T, Pedraza A, Etienne J, Novick RP, Vandenesch F. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol. Microbiol. 28:655-662. http://dx.doi.org/10.1046/j.1365-2958.1998 .00830.x.
50. Lyon GJ, Wright JS, Muir TW, Novick RP. 2002. Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus. Biochemistry 41:10095-10104. http://dx.doi.org/10.1021/bi026049u.
51. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
52. Koenig RL, Ray JL, Maleki SJ, Smeltzer MS, Hurlburt BK. 2004. Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J. Bacteriol. 186:7549-7555. http://dx.doi.org/10.1128/JB.186.22.7549 -7555.2004.
53. Morfeldt E, Taylor D, von Gabain A, Arvidson S. 1995. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 14:4569-4577.
54. Vandenesch F, Kornblum J, Novick RP. 1991. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J. Bacteriol. 173:6313-6320.
55. Cheung AL, Chien YT, Bayer AS. 1999. Hyperproduction of alphahemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus. Infect. Immun. 67:1331-1337.
56. Wright JS, III, Jin R, Novick RP. 2005. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc. Natl. Acad. Sci. U. S. A. 102:1691-1696. http://dx.doi.org/10.1073/pnas.0407661102.
57. Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick RP, Muir TW. 1999. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc. Natl. Acad. Sci. U. S. A. 96:1218-1223. http://dx.doi.org/10.1073/pnas.96 .4.1218.
58. Geiger T, Francois P, Liebeke M, Fraunholz M, Goerke C, Krismer B, Schrenzel J, Lalk M, Wolz C. 2012. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog. 8:e1003016. http://dx.doi.org/10.1371/journal.ppat.1003016.
59. Bhakdi S, Muhly M, Korom S, Hugo F. 1989. Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect. Immun. 57:3512-3519.
60. Suttorp N, Seeger W, Dewein E, Bhakdi S, Roka L. 1985. Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. Am. J. Physiol. 248:C127-C134.
61. Rose F, Dahlem G, Guthmann B, Grimminger F, Maus U, Hanze J, Duemmer N, Grandel U, Seeger W, Ghofrani HA. 2002. Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureus alpha-toxin. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L207-L214.
62. Suttorp N, Fuhrmann M, Tannert-Otto S, Grimminger F, Bhadki S. 1993. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J. Exp. Med. 178:337-341. http://dx.doi.org /10.1084/jem.178.1.337.
63. Suttorp N, Buerke M, Tannert-Otto S. 1992. Stimulation of PAFsynthesis in pulmonary artery endothelial cells by Staphylococcus aureus alpha-toxin. Thromb. Res. 67:243-252. http://dx.doi.org/10.1016/0049 -3848(92)90143-X.
64. Onogawa T. 2002. Staphylococcal alpha-toxin synergistically enhances inflammation caused by bacterial components. FEMS Immunol. Med. Microbiol. 33:15-21. http://dx.doi.org/10.1111/j.1574-695X.2002.tb00566.x.
65. Becker RE, Berube BJ, Sampedro GR, Dedent AC, Bubeck Wardenburg J. 10 May 2014. Tissue-specific patterning of host innate immune responses by Staphylococcus aureus alpha-toxin. J. Innate Immun. http://dx .doi.org/10.1159/000360006.
66. Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL, Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI, Miller LS. 2012. Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 8:e1003047. http://dx.doi.org/10.1371/journal.ppat.1003047.
67. Nygaard TK, Pallister KB, DuMont AL, DeWald M, Watkins RL, Pallister EQ, Malone C, Griffith S, Horswill AR, Torres VJ, Voyich JM. 2012. Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS One 7:e36532. http: //dx.doi.org/10.1371/journal.pone.0036532.
68. Surewaard BG, Nijland R, Spaan AN, Kruijtzer JA, de Haas CJ, van Strijp JA. 2012. Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog. 8:e1002606. http://dx.doi .org/10.1371/journal.ppat.1002606.
69. Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22:240-273. http://dx .doi.org/10.1128/CMR.00046-08.
70. Medzhitov R, Janeway C, Jr. 2000. Innate immunity. N. Engl. J. Med. 343:338-344. http://dx.doi.org/10.1056/NEJM200008033430506.